Abstract: The invention relates to the use of microjet reactor for processing biomass. The cell lysis of flowable biomass is thereby carried out by means of multiple high-speed liquid jets which collide with one another, wherein the liquid jets contain the cells or consist wholly of the flowable cell mass, wherein intact or wholly or partially lysed biomass is added to at least one of the colliding high-speed liquid jets, and an extraction takes place simultaneously with the collision of the liquid jets or subsequently thereto. The lysis of the cells is initiated or facilitated by the forces that occur on acceleration, introduction of the acceleration, collision of the jets and mixing of the jet constituents.

Abstract: The invention relates to a method for preparing emulsions. In order to create a new method for preparing emulsions, in which homogenous oil droplets as small as possible can be generated with an energy input as low as possible, it is proposed in the scope of the invention, that at least two liquid streams of liquids that cannot be intermixed with one another are pumped through separate openings with defined diameters, in order to achieve flow velocity of the liquid streams of more than 10 m/sec., and in that the liquid streams collide at a collision point in a space, wherein the resulting emulsion is discharged from the space through an outlet. By the collision of the liquid streams with high flow velocities, in which a plate-shaped collision plate is formed in the collision point, a homogenous emulsion having an oil droplet size of less than 1 ?m is achieved due to the kinetic energy, which is accordingly very stable as well. No further energy input, such as shear forces, is required to that end.

Abstract: The invention relates to an apparatus and method for the production of dispersions and solids by way of controlled precipitation, co-precipitation and self-organization processes in a microjet reactor, a jet of solvent containing at least one target molecule and a jet of nonsolvent colliding with each other, at specified pressures and flow rates, at a collision point in the reactor chamber of the microjet reactor, and the microjet reactor having a gas inlet for introducing gas into the reactor chamber and an educt outlet for discharging the educts in a stream of gas. This results in very rapid precipitation, co-precipitation or a chemical reaction, during the course of which micro- or nanoparticles form.

Abstract: The present invention is directed to a pharmaceutical composition comprising guanfacine or a salt thereof in nanoparticle form and at least one non-pH dependent sustained release agent. The present invention further is directed to a method of producing said nanoparticles and to nanoparticles obtained by this method.

Abstract: The present invention is directed to a pharmaceutical composition comprising guanfacine or a salt thereof in nano particle form and at least one non-pH dependent sustained release agent. The present invention further is directed to a method of producing said nanoparticles and to nanoparticles obtained by this method.

Abstract: The invention relates to an apparatus and method for the production of dispersions and solids by way of controlled precipitation, co-precipitation and self-organisation processes in a microjet reactor, a jet of solvent containing at least one target molecule and a jet of nonsolvent colliding with each other, at specified pressures and flow rates, at a collision point in the reactor chamber of the microjet reactor, and the microjet reactor having a gas inlet for introducing gas into the reactor chamber and an educt outlet for discharging the educts in a stream of gas. This results in very rapid precipitation, co-precipitation or a chemical reaction, during the course of which micro- or nanoparticles form.

Abstract: The present invention is related to the field of pharmaceutical compositions for the treatment of various disease states, particularly neoplastic diseases and autoimmune diseases. It especially relates to the oral application of bendamustine and its derivatives. The invention further relates to a process for preparing a pharmaceutical composition which comprises bendamustine and its derivatives prepared by hot melt extrusion using pharmaceutically acceptable excipients. The invention also relates to such pharmaceutical compositions and hot melt extrudates.

Abstract: The invention relates to a method for producing microparticles or nanoparticles of water-soluble and water-insoluble substances by controlled precipitation, co-precipitation and self-organization processes in microjet reactors, a solvent, which contains at least one target molecule, and a nonsolvent being mixed as jets that collide with each other in a microjet reactor at defined pressures and flow rates and thereby effect very rapid precipitation, co-precipitation or a chemical reaction, during the course of which microparticles or nanoparticles are formed.

Abstract: Pharmaceutical drug particles of small particle size are produced by combining a solvent-non-solvent precipitate with an in-situ spray drying process. A pharmaceutical drug is dispersed in a water-miscible solvent, in particular ethanol, and heated in an infeed line under pressure to above the boiling point of the solvent until the drug dissolves. This solution collides as a fine liquid jet with a fine water jet in a gas-permeated microreactor, and the fine mist so arising vaporises rapidly. The organic solvent vaporizes first, then the water. The water may contain surface modifiers.

Abstract: The invention relates to a method for producing microparticles or nanoparticles of water-soluble and water-insoluble substances by controlled precipitation, co-precipitation and self-organization processes in microjet reactors, a solvent, which contains at least one target molecule, and a nonsolvent being mixed as jets that collide with each other in a microjet reactor at defined pressures and flow rates and thereby effect very rapid precipitation, co-precipitation or a chemical reaction, during the course of which microparticles or nanoparticles are formed.

Abstract: Pharmaceutical drug particles of small particle size are produced by combining a solvent-non-solvent precipitate with an in-situ spray drying process. A pharmaceutical drug is dispersed in a water-miscible solvent, in particular ethanol, and heated in an infeed line under pressure to above the boiling point of the solvent until the drug dissolves. This solution collides as a fine liquid jet with a fine water jet in a gas-permeated microreactor, and the fine mist so arising vaporises rapidly. The organic solvent vaporizes first, then the water. The water may contain surface modifiers.